The case for life expectancy at age 60 as a prominent health indicator. A comparative analysis

The aim of this paper is to argue the case of using life expectancy at age 60 (LE60) as a significant health indicator closely related to sustainable economic development. To this purpose, we investigate the impact of GDP on LE60 in parallel with the impact of GDP on Infant Mortality Rate (IMR). The...

Full description

Bibliographic Details
Main Author: Iulia Toropoc
Format: Article
Language:English
Published: AIMS Press 2022-12-01
Series:National Accounting Review
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/NAR.2022022?viewType=HTML
_version_ 1797962654398021632
author Iulia Toropoc
author_facet Iulia Toropoc
author_sort Iulia Toropoc
collection DOAJ
description The aim of this paper is to argue the case of using life expectancy at age 60 (LE60) as a significant health indicator closely related to sustainable economic development. To this purpose, we investigate the impact of GDP on LE60 in parallel with the impact of GDP on Infant Mortality Rate (IMR). The rationale for selecting IMR as a comparison indicator is twofold. First, the relationship between IMR and GDP has been widely studied. Second, the two indicators display opposite trajectories, making the comparison more striking. For our comparison, we conduct several statistical analyses on LE60, IMR and GDP using global country data grouped by income level and region. Our results endorse the effect of GDP on LE60 and IMR and suggest a differentiation of the effect based on region and ultimately on income. We observe that as countries develop, their IMR values lower and their LE60 values increase. We conclude that, once countries reach the upper stages of development, LE60 becomes a better health indicator than IMR.
first_indexed 2024-04-11T01:17:24Z
format Article
id doaj.art-70811bb8cc8444eaa2caad47dba96f20
institution Directory Open Access Journal
issn 2689-3010
language English
last_indexed 2024-04-11T01:17:24Z
publishDate 2022-12-01
publisher AIMS Press
record_format Article
series National Accounting Review
spelling doaj.art-70811bb8cc8444eaa2caad47dba96f202023-01-04T02:08:55ZengAIMS PressNational Accounting Review2689-30102022-12-014439041110.3934/NAR.2022022The case for life expectancy at age 60 as a prominent health indicator. A comparative analysisIulia Toropoc0Independent Researcher, 172 Holland Park Avenue, London, United KingdomThe aim of this paper is to argue the case of using life expectancy at age 60 (LE60) as a significant health indicator closely related to sustainable economic development. To this purpose, we investigate the impact of GDP on LE60 in parallel with the impact of GDP on Infant Mortality Rate (IMR). The rationale for selecting IMR as a comparison indicator is twofold. First, the relationship between IMR and GDP has been widely studied. Second, the two indicators display opposite trajectories, making the comparison more striking. For our comparison, we conduct several statistical analyses on LE60, IMR and GDP using global country data grouped by income level and region. Our results endorse the effect of GDP on LE60 and IMR and suggest a differentiation of the effect based on region and ultimately on income. We observe that as countries develop, their IMR values lower and their LE60 values increase. We conclude that, once countries reach the upper stages of development, LE60 becomes a better health indicator than IMR.https://www.aimspress.com/article/doi/10.3934/NAR.2022022?viewType=HTMLpopulationpopulation aginglife expectancy at age 60infant mortality rateeconomic developmenthealth indicatorincomeregioninequalitycorruption
spellingShingle Iulia Toropoc
The case for life expectancy at age 60 as a prominent health indicator. A comparative analysis
National Accounting Review
population
population aging
life expectancy at age 60
infant mortality rate
economic development
health indicator
income
region
inequality
corruption
title The case for life expectancy at age 60 as a prominent health indicator. A comparative analysis
title_full The case for life expectancy at age 60 as a prominent health indicator. A comparative analysis
title_fullStr The case for life expectancy at age 60 as a prominent health indicator. A comparative analysis
title_full_unstemmed The case for life expectancy at age 60 as a prominent health indicator. A comparative analysis
title_short The case for life expectancy at age 60 as a prominent health indicator. A comparative analysis
title_sort case for life expectancy at age 60 as a prominent health indicator a comparative analysis
topic population
population aging
life expectancy at age 60
infant mortality rate
economic development
health indicator
income
region
inequality
corruption
url https://www.aimspress.com/article/doi/10.3934/NAR.2022022?viewType=HTML
work_keys_str_mv AT iuliatoropoc thecaseforlifeexpectancyatage60asaprominenthealthindicatoracomparativeanalysis
AT iuliatoropoc caseforlifeexpectancyatage60asaprominenthealthindicatoracomparativeanalysis